Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: A retrospective cohort study

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 11, Issue 5, 2014, Pages 521-530

  Wurst, Keele E ^a   Shukla, Amit ^a   Muellerova, Hana ^b   Davis, Kourtney J ^c  

^a GLAXOSMITHKLINE   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

^c GSK   (Belgium)

Author keywords

GOLD strategy; inhaled corticosteroids; long acting bronchodilators; newly diagnosed COPD; primary care; short acting bronchodilators

Indexed keywords

ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; MUSCARINIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DRUG THERAPY; DYSPNEA; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; UNITED KINGDOM; CLINICAL PRACTICE; FACTUAL DATABASE; FORCED EXPIRATORY VOLUME; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; PATHOPHYSIOLOGY; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-2 RECEPTOR AGONISTS; AGED; BRONCHODILATOR AGENTS; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; FORCED EXPIRATORY VOLUME; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84907052573     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2014.922064     Document Type: Article

References (34)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (updated). 2013. Available from: http://www.goldcopd.org/uploads/users/fi les/GOLDReport2013Feb20.pdf.
2. Antus B. Pharmacotherapy of chronic obstructive pulmonary disease: a clinical review. ISRN Pulmonology 2013; 2013.
3. Qaseem A, Wilt TJ, Weinberger SE, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Th oracic Society, and European Respiratory Society. Ann Intern Med 2011; 155(3):179-191.
4. NICE. Management of chronic obstructive pulmonary disease in adults in primary and secondary care (partial update). 2010. Available from: http://www.nice.org.uk/nicemedia/live/13029/49397/49397.pdf. Accessed: 2012 December 3.
5. Diette GB, Orr P, McCormack MC, et al. Is pharmacologic care of chronic obstructive pulmonary disease consistent with the guidelines Popul Health Manag 2010; 13(1):21-26.
6. Fitch K, Iwasaki K, Pyenson B, et al. Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis. Curr Med Res Opin 2011; 27(7):1425-1429.
7. Jochmann A, Neubauer F, Miedinger D, et al. General practitioner's adherence to the COPD GOLD guidelines: baseline data of the Swiss COPD Cohort Study. Swiss Med Wkly 2010;21 Apr.
8. Perez X, Wisnivesky JP, Lurslurchachai L, et al. Barriers to adherence to COPD guidelines among primary care providers. Respir Med 2012; 106(3):374-381.
9. Salinas GD, Williamson JC, Kalhan R, et al. Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians. Int J Chron Obstruct Pulmon Dis 2011; 6:171-179.
10. The Royal College of Physicians of London, British Th oracic Society, British Lung Foundation. Report 5 of The National Chronic Obstructive Pulmonary Disease Audit 2008: survey of COPD care within UK General Practices. London, UK: Royal College of Physicians; 2008. Report No. 5.
11. Heins-Nesvold J, Carlson A, King-Schultz L, et al. Patient identifi ed needs for chronic obstructive pulmonary disease versus billed services for care received. Int J Chron Obstruct Pulmon Dis 2008; 3(3):415-421.
12. Aisanov Z, Bai C, Bauerle O, et al. Primary care physician perceptions on the diagnosis and management of chronic obstructive pulmonary disease in diverse regions of the world. Int J Chron Obstruct Pulmon Dis 2012; 7:271-282.
13. Soriano JB, Maier WC, Visick G, et al. Validation of general practitioner-diagnosed COPD in the UK General Practice Research Database. Eur J Epidemiol 2001; 17(12):1075-1080.
14. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991; 302(6779):766-768.
15. NHS Employers. Quality and outcomes framework guidance for GMS contract 2009/10. March 2009. Available from: http://www.nhsemployers.org/aboutus/publications/documents/qof-guidance-2009-fi nal.pdf. Accessed: 2012 December 3.
16. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. 2006. Available from: http://www.who.int/respiratory/copd/GOLD-WR-06.pdf. Accessed: 2013 June 17.
17. Khan NF, Perera R, Harper S, et al. Adaptation and validation of the Charlson Index for Read/OXMIS coded databases. BMC Fam Pract 2010; 11:1.
18. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Th orax 1999; 54(7):581-586.
19. NICE. MRC dyspnoea scale. 2007. Available from: http://www.nice.org.uk/usingguidance/commissioningguides/pulmonaryrehabilitationserviceforpatientswithcopd/mrc-dyspnoea-scale.jsp. Accessed: 2013 January 10.
20. Bastin AJ, Starling L, Ahmed R, et al. High prevalence of undiagnosed and severe chronic obstructive pulmonary disease at fi rst hospital admission with acute exacerbation. Chron Respir Dis 2010; 7(2):91-97.
21. Cazzola M, Segreti A, Bettoncelli G, et al. Change in asthma and COPD prescribing by Italian general practitioners between 2006 and 2008. Prim Care Respir J 2011; 20(3):291-298.
22. Minas M, Hatzoglou C, Karetsi E, et al. COPD prevalence and the diff erences between newly and previously diagnosed COPD patients in a spirometry program. Prim Care Respir J 2010; 19(4):363-370.
23. Jones PW, Brusselle G, Dal Negro RW, et al. Patient-centred assessment of COPD in primary care: experience from a crosssectional study of health-related quality of life in Europe. Prim Care Respir J 2012; 21(3):329-336.
24. Greening NJ, Evans RA, Williams JE, et al. Does body mass index infl uence the outcomes of a Waking-based pulmonary rehabilitation programme in COPD Chron Respir Dis 2012; 9(2):99-106.
25. Bischoff EW, Schermer TR, Bor H, et al. Trends in COPD prevalence and exacerbation rates in Dutch primary care. Br J Gen Pract 2009; 59(569):927-933.
26. Roche N, Lepage T, Bourcereau J, et al. Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease. Eur Respir J 2001;18(6):903-908.
27. Asche CV, Leader S, Plauschinat C, et al. Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of longacting bronchodilators or inhaled corticosteroids. Int J Chron Obstruct Pulmon Dis 2012; 7:201-209.
28. Bourbeau J, Sebaldt RJ, Day A, et al. Practice patterns in the management of chronic obstructive pulmonary disease in primary practice: the CAGE study. Can Respir J 2008; 15(1):13-19.
29. Chavez PC, Shokar NK. Diagnosis and management of chronic obstructive pulmonary disease (COPD) in a primary care clinic. COPD 2009;6(6):446-451.
30. Cazzola M, Bettoncelli G, Sessa E, et al. Primary care of the patient with chronic obstructive pulmonary disease in Italy. Respir Med 2009; 103(4):582-588.
31. Desalu OO, Onyedum CC, Adeoti AO, et al. Guideline-based COPD management in a resource-limited setting-physicians' understanding, adherence and barriers: a cross-sectional survey of internal and family medicine hospital-based physicians in Nigeria. Prim Care Respir J 2013; 22(1):79-85.
32. Seaman J, Leonard AC, Panos RJ. Health care utilization history, GOLD guidelines, and respiratory medication prescriptions in patients with COPD. Int J Chron Obstruct Pulmon Dis 2010; 5:89-97.
33. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease (revised). December 2011. Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html. Accessed: 2012 December 3.
34. GPRD database. August 2010. Available from: http://www. itmat.upenn.edu/ctsa/acard/docs/all-Description-GPRD-FINAL.pdf. Accessed: 2013 January 10.